The new Russian vaccine against the coronavirus, christened Sputnik V, will be administered to the first volunteers from this week as part of the third phase of clinical studies after its registration, Russian Health Minister Mikhail Murashko reports.
“This week, the vaccination of the volunteers who will take part in the third phase of clinical trials begins,” said the Russian Minister of Health, according to the Russian news agency Sputnik.
The Russian National Office for Consumer Protection (Rospotrebnadzor) has reported that the clinical trials conducted by the Vector Virology and Biotechnology Center with the Russian vaccine will be completed on September 30th.
The Russian authorities officially registered their first vaccine against COVID-19 on August 11, which was developed by the Gamaleya Center for Epidemiology and Microbiology. The Sputnik V vaccine produces immunity for a period of two years.
At the current stage, the vaccine is being used in tests with a special authorization that allows it to be given only to people in risk groups and under strict control.